UK Medical Research Council randomised, multicentre trial of interferon-αn1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response

This publication has 17 references indexed in Scilit:

• Interferon Alfa-2a as Compared with Conventional Chemotherapy for the Treatment of Chronic Myeloid Leukemia
  New England Journal of Medicine, 1994
• The Role of Interferon in the Treatment of Chronic Myelogenous Leukemia: Results and Prospects
  Leukemia & Lymphoma, 1992
• Interferon alfa-2b in acute- and chronic-phase chronic myelogenous leukaemia: Initial response and long-term results in 54 patients
  European Journal of Cancer and Clinical Oncology, 1991
• Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administration
  Blood, 1988
• Clinical investigation of human alpha interferon in chronic myelogenous leukemia
  Blood, 1987
• Results of treatment of Ph'+ chronic myelogenous leukemia with an intensive treatment regimen (L-5 protocol)
  Blood, 1979
• Remission Induction in Chronic Granulocytic Leukaemia using Intermittent High-Dose Busulphan
  British Journal of Haematology, 1978
• Chronic Granulocytic Leukaemia with Ph1 Negative Cells in Bone Marrow and a Ten Year Remission after Busulphan Hypoplasia
  British Journal of Haematology, 1972
• Busulphan and bone marrow depression.
  BMJ, 1969
• MYLERAN IN CHRONIC MYELOID LEUKÆMIA RESULTS OF TREATMENT
  The Lancet, 1953